May is Prader-Willi Syndrome (PWS) Awareness Month and the worldwide PWS community is coming together to spread awareness about…
Marisa Horak, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Horak, MS
Researchers have successfully used the gene-editing tool CRISPR to reactivate certain maternally-inherited genes that can compensate for the loss of…
People with Prader-Willi syndrome (PWS) caused by a genetic deletion are significantly more likely to have…
The Prader-Willi Syndrome Association USA (PWSA) has again been named a winner of the Patients at the Heart…
CSTI-500, an experimental oral therapy that ConSynance Therapeutics is developing to ease symptoms of Prader-Willi syndrome (PWS), showed…
The case of a young man with Prader-Willi syndrome who developed Hoffman’s syndrome, a condition marked by muscle weakness…
Children with Prader-Willi syndrome (PWS) who start on treatment with growth hormone in the first year of life tend…
Early treatment with Jintropin, a form of human growth hormone, was associated with improvements in cognition and appeared to slow…
The Foundation for Prader-Willi Research has awarded a two-year, $141,444 grant to help fund the development…
Compared to their typically developing peers, children with Prader-Willi syndrome show marked differences in the shapes and sizes of…